Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (461-470 of 505) with videos related to

Pageof 51
Sort By:
Respiratory Research|July 16, 2020
The sputum microbiome is distinct between COPD and health, independent of smoking historyKoirobi Haldar, Leena George, Zhang Wang, et al.
The Lancet. Respiratory Medicine|July 9, 2019
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trialSteven Pascoe, Neil Barnes, Guy Brusselle, et al.
Allergy|September 9, 2024
Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthmaHorace Rhee, Lindsay M Henderson, Rebecca N Bauer, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2020
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Courtney Crim, Gerard J Criner, et al.
Trials|August 2, 2020
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trialTom Wilkinson, Rupert Dixon, Clive Page, et al.
The Lancet. Respiratory Medicine|October 2, 2025
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational studyStanley P Galant, Pauline J M Kuks, Tessa M Kole, et al.
Allergy|November 10, 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS CohortPauline J M Kuks, Tatiana Karp, Jorine E Hartman, et al.
European Journal of Radiology|September 2, 2014
Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPDAlexandra R Morgan, Geoff J M Parker, Caleb Roberts, et al.
The Lancet Regional Health. Europe|May 3, 2023
Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal studyDavid M G Halpin, Andrew P Dickens, Derek Skinner, et al.
Thorax|December 23, 2017
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP studyZhang Wang, Richa Singh, Bruce E Miller, et al.
Pageof 51

Showing results (461-470 of 505) with videos related to

Sort By:
Pageof 51
Respiratory Research|July 16, 2020
The sputum microbiome is distinct between COPD and health, independent of smoking historyKoirobi Haldar, Leena George, Zhang Wang, et al.
The Lancet. Respiratory Medicine|July 9, 2019
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trialSteven Pascoe, Neil Barnes, Guy Brusselle, et al.
Allergy|September 9, 2024
Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthmaHorace Rhee, Lindsay M Henderson, Rebecca N Bauer, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2020
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Courtney Crim, Gerard J Criner, et al.
Trials|August 2, 2020
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trialTom Wilkinson, Rupert Dixon, Clive Page, et al.
The Lancet. Respiratory Medicine|October 2, 2025
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational studyStanley P Galant, Pauline J M Kuks, Tessa M Kole, et al.
Allergy|November 10, 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS CohortPauline J M Kuks, Tatiana Karp, Jorine E Hartman, et al.
European Journal of Radiology|September 2, 2014
Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPDAlexandra R Morgan, Geoff J M Parker, Caleb Roberts, et al.
The Lancet Regional Health. Europe|May 3, 2023
Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal studyDavid M G Halpin, Andrew P Dickens, Derek Skinner, et al.
Thorax|December 23, 2017
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP studyZhang Wang, Richa Singh, Bruce E Miller, et al.
Pageof 51